December Global Macro Monthly - Omicron – the ghost of Christmas past?
- 17 December 2021 (10 min read)
Key points
- The Omicron variant presents a new and as yet undefined risk to the growth outlook for 2022. Evidence on the severity of infections will define the likely growth impact.
- Despite growth softening with supply constraints, the outlook for next year should be for further solid recovery. Inflation continues to rise but should be close to a peak in several jurisdictions.
- Labour market differences will shape medium-term inflation risks. Tight labour markets in the UK and Canada make the Bank of England and Bank of Canada look likely early tighteners. The Federal Reserve is tapering more quickly and can tighten earlier in 2022. The European Central Bank has announced its own taper for 2022.
- Rates and credit markets are positioned for faster Fed rate tightening, while the dollar could benefit further. ECB-Fed rate divergence poses some risk to European equity risk premia, but we remain constructive in outlook.
Disclaimer
This website is published by AXA Investment Managers Asia Limited (“AXA IM HK”), an entity licensed by the Securities and Futures Commission of Hong Kong (“SFC”), for general circulation and informational purposes only. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy, sell or enter into any transactions in respect of any investments, products or services, and should not be considered as solicitation or investment, legal, tax or any other advice, a recommendation for an investment strategy or a personalised recommendation to buy or sell securities under any applicable law or regulation. It has been prepared without taking into account the specific personal circumstances, investment objectives, financial situation, investment knowledge or particular needs of any particular person and may be subject to change at any time without notice. Offering may be made only on the basis of the information disclosed in the relevant offering documents. Please consult independent financial or other professional advisers if you are unsure about any information contained herein.
Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee such opinions, estimates and forecasts made will come to pass. Actual results of operations and achievements may differ materially. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Information herein may be obtained from sources believed to be reliable. AXA IM HK has reasonable belief that such information is accurate, complete and up-to-date. To the maximum extent permitted by law, AXA IM HK, its affiliates, directors, officers or employees take no responsibility for the data provided by third party, including the accuracy of such data. This material does not contain sufficient information to support an investment decision. References to companies (if any) are for illustrative purposes only and should not be viewed as investment recommendations or solicitations.
All investment involves risk, including the loss of capital. The value of investments and the income from them can fluctuate and that past performance is no guarantee of future returns, investors may not get back the amount originally invested. Investors should not make any investment decision based on this material alone.
Some of the services listed on this Website may not be available for offer to retail investors.
This Website has not been reviewed by the SFC. © 2024 AXA Investment Managers. All rights reserved.